The emerging role of microRNAs in multiple sclerosis

Andreas Junker1, Reinhard Hohlfeld, Edgar Meinl

  • 1Department of Neuropathology, University Medical Center, Georg August University, Robert-Koch-Strasse 40, 37075 Göttingen, Germany.

Nature Reviews. Neurology
|December 15, 2010
PubMed

Insights

MicroRNAs (miRNAs) play a role in multiple sclerosis (MS) pathogenesis by altering immune cell function and myelin maintenance. Understanding these miRNA changes could lead to new MS therapies and biomarkers.

Area of Science:

  • Neuroimmunology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators of gene expression, influencing numerous biological processes.
  • Altered miRNA profiles are observed in multiple sclerosis (MS) patients' blood cells and lesions.
  • Specific miRNAs are implicated in the immune responses and myelin sheath maintenance relevant to MS.

Purpose of the Study:

  • To discuss the potential role of miRNAs in the pathogenesis of multiple sclerosis (MS).
  • To explore how dysregulated miRNAs contribute to MS pathology, including immune cell involvement and myelin damage.
  • To highlight the potential of miRNAs as therapeutic targets and biomarkers for MS.

Main Methods:

  • Review of recent studies on miRNA expression in multiple sclerosis.
  • Analysis of miRNA profiles in blood cells and MS lesions.
  • Discussion of the functional roles of specific miRNAs (e.g., miRNA-326, miRNA-219) in immune cells and oligodendrocytes.

Main Results:

  • Distinct miRNA expression patterns exist in active versus inactive MS lesions.
  • Dysregulated miRNAs in MS lesions are linked to astrocytes and immune cells, potentially affecting macrophage activity via CD47.
  • Increased miRNA-326 in blood during relapses correlates with T helper 17 cell differentiation and is found in active MS lesions.
  • miRNAs are essential for myelin sheath maintenance; their absence causes axonal damage.
  • miRNA-219 and others promote oligodendrocyte differentiation.

Conclusions:

  • MicroRNAs are significantly implicated in multiple sclerosis pathogenesis.
  • Dysregulation of specific miRNAs contributes to immune dysregulation and myelin damage in MS.
  • Further understanding of miRNA involvement may reveal novel therapeutic strategies and diagnostic biomarkers for MS.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...